UK MS drug shortage leaves patient in severe pain; supply crisis persists

A UK-wide shortage of a medication used to manage multiple sclerosis has left a patient, Jill Kenning, unable to access her treatment, causing severe pain. The shortage reflects broader supply chain disruptions affecting the NHS, with no clear timeline for resolution. This highlights vulnerabilities in pharmaceutical supply chains and potential public health impact.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works